Pre-order Enquiry
Request Free Sample
Global Hemoglobin A1C Analyzer Market Insights and Forecast to 2027
SKU ID : QYR-18151908 | Publishing Date : 29-Apr-2021 | No. of pages : 114
Request Sample
Request Customization
Check Discounts
Hemoglobin is a protein found in the red blood cells. Its job is to carry oxygen from the lungs to all other parts of the body. Hemoglobin also has the ability to bind with glucose in the bloodstream; this type of bonding is called glycation.
The glycation process is irreversible so glycated hemoglobin (HbA1c) remains in its evolved state for the lifespan of the red blood cell - approximately 8-12 weeks. By measuring the amount of HbA1c in the blood it is possible to determine average blood glucose control over an 8-12 week period. The more HbA1c in your blood, the less controlled a patient’s diabetes is and the more susceptible they are to developing long-term health complications.
HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.
The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels.
The industry's leading producers are Abbott Laboratories, Roche and Siemens, with revenues of 19.20%, 13.11% and 7.95% respectively in 2019.
Market Analysis and Insights: Global Hemoglobin A1C Analyzer Market
The global Hemoglobin A1C Analyzer market is valued at US$ 1355.4 million in 2019. The market size will reach US$ 2487.8 million by the end of 2026, growing at a CAGR of 9.2% during 2021-2026.
Global Hemoglobin A1C Analyzer Scope and Market Size
Hemoglobin A1C Analyzer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemoglobin A1C Analyzer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Bench-top
Compact
Portable
Segment by Application
Hospital
Homecare
Others
By Company
Abbott Laboratories
Roche
Siemens
Bio-Rad Laboratories
Tosoh
Danaher Corporation
Trinity Biotech
HUMAN Diagnostics
Arkray
OSANG Healthcare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
The glycation process is irreversible so glycated hemoglobin (HbA1c) remains in its evolved state for the lifespan of the red blood cell - approximately 8-12 weeks. By measuring the amount of HbA1c in the blood it is possible to determine average blood glucose control over an 8-12 week period. The more HbA1c in your blood, the less controlled a patient’s diabetes is and the more susceptible they are to developing long-term health complications.
HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.
The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels.
The industry's leading producers are Abbott Laboratories, Roche and Siemens, with revenues of 19.20%, 13.11% and 7.95% respectively in 2019.
Market Analysis and Insights: Global Hemoglobin A1C Analyzer Market
The global Hemoglobin A1C Analyzer market is valued at US$ 1355.4 million in 2019. The market size will reach US$ 2487.8 million by the end of 2026, growing at a CAGR of 9.2% during 2021-2026.
Global Hemoglobin A1C Analyzer Scope and Market Size
Hemoglobin A1C Analyzer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemoglobin A1C Analyzer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Bench-top
Compact
Portable
Segment by Application
Hospital
Homecare
Others
By Company
Abbott Laboratories
Roche
Siemens
Bio-Rad Laboratories
Tosoh
Danaher Corporation
Trinity Biotech
HUMAN Diagnostics
Arkray
OSANG Healthcare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
